Kaiser Permanente study published in the journal Gastroenterology supports starting screening at age 45 among this higher-risk population.
Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.
Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication.
Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.